The UK Competition Appeal Tribunal announces its provisional judgment in an appeal against the Competition Authority's infringement decision in an excessive price case (Pfizer / Flynn)

Killick, James; Komninos, Assimakis

Previous article The Canadian Supreme Court dismisses an appeal and upholds the Court of Appeal’s order requiring a professional association to stop restricting its members’ use of real estate data (Toronto Real Estate Board) Next article The UK Competition Appeal Tribunal partly annuls the Competition Authority’s decision that pharmaceutical companies abused their dominant position by setting excessive and unfair prices for an epilepsy drug (Pfizer / Flynn)

7 Jun 2018

The UK Competition Appeal Tribunal announces its provisional judgment in an appeal against the Competition Authority’s infringement decision in an excessive price case (Pfizer / Flynn)

KEYWORDS

Reference

UK Competition Appeal Tribunal, Pfizer / Flynn, n° 1275-1276/1/12/17, 7 June 2018

I. Introduction In the last couple of years, there has been a trend for antitrust watchdogs around the world to investigate excessive pricing, especially in the pharmaceutical sector. Last year, the European Commission opened its first investigation into excessive pricing in the pharmaceutical sector into the prices of Aspen’s cancer drugs. This followed on from an investigation by the Italian competition authority fining Aspen EUR 5.2 million in 2016 for the pricing of the same drugs. Similar cases were also pursued in South Africa. In the UK, the Competition and Markets Authority (“CMA”) opened a number of investigations of which at least two are ongoing and adopted a decision imposing large fines on Pfizer and Flynn Pharma (“Flynn”). This outbreak of excessive pricing investigations

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Authors

James Killick
White & Case (Brussels)

Belgium 53 contributions 54612 visits
Assimakis Komninos
White & Case (Brussels)

Belgium 36 contributions 63024 visits

Quotation

James Killick, Assimakis Komninos, The UK Competition Appeal Tribunal announces its provisional judgment in an appeal against the Competition Authority’s infringement decision in an excessive price case (Pfizer / Flynn), 7 June 2018, e-Competitions Burden of proof, Art. N° 87652

Visites 605